Inhibition of Wnt/β-catenin signaling by p38 MAP kinase inhibitors is explained by cross-reactivity with casein kinase Iδ/ɛ.

Wnt/β-catenin signaling plays essential roles in embryonic development, adult stem cell maintenance, and disease. Screening of a small molecule compound library with a β-galactosidase fragment complementation assay measuring β-catenin nuclear entry revealed TAK-715 and AMG-548 as inhibitors of Wnt-3a-stimulated β-catenin signaling. TAK-715 and AMG-548 are inhibitors of p38 mitogen-activated protein kinase, which has been suggested to regulate activation of Wnt/β-catenin signaling. However, two highly selective and equally potent p38 inhibitors, VX-745 and Scio-469, did not inhibit Wnt-3a-stimulated β-catenin signaling. Profiling of TAK-715 and AMG-548 against a panel of over 200 kinases revealed cross-reactivity with casein kinase Iδ and ɛ, which are known activators of Wnt/β-catenin signaling. Our data demonstrate that this cross-reactivity accounts for the inhibition of β-catenin signaling by TAK-715 and AMG-548 and argue against a role of p38 in Wnt/β-catenin signaling.

[1]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[2]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[3]  C. Dominguez,et al.  p38 MAP kinase inhibitors: many are made, but few are chosen. , 2005, Current opinion in drug discovery & development.

[4]  B. Dérijard,et al.  Transcription factor ATF2 regulation by the JNK signal transduction pathway , 1995, Science.

[5]  M. Cotten,et al.  An efficient proteomics method to identify the cellular targets of protein kinase inhibitors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Ninomiya-Tsuji,et al.  Regulation of Lymphoid Enhancer Factor 1/T-Cell Factor by Mitogen-Activated Protein Kinase-Related Nemo-Like Kinase-Dependent Phosphorylation in Wnt/β-Catenin Signaling , 2003, Molecular and Cellular Biology.

[7]  Xi He,et al.  A mechanism for Wnt coreceptor activation. , 2004, Molecular cell.

[8]  T. Holbro,et al.  Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells (EMBO reports, February 2003) (Correction) , 2003, EMBO reports.

[9]  F. McCormick,et al.  Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling* , 2000, The Journal of Biological Chemistry.

[10]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[11]  J. Nathans,et al.  A new secreted protein that binds to Wnt proteins and inhibits their activites , 1999, Nature.

[12]  Sung-Eun Kim,et al.  EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation. , 2007, Cellular signalling.

[13]  J. Caverzasio,et al.  Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells. , 2007, Endocrinology.

[14]  C. Malbon,et al.  p38 mitogen-activated protein kinase regulates canonical Wnt–β-catenin signaling by inactivation of GSK3β , 2008, Journal of Cell Science.

[15]  H. Yost,et al.  Regulation of Casein Kinase Iϵ Activity by Wnt Signaling* , 2004, Journal of Biological Chemistry.

[16]  Hans Clevers,et al.  Mining the Wnt pathway for cancer therapeutics , 2007, Nature Reviews Drug Discovery.

[17]  H. Clevers.  Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[18]  Martin Egli,et al.  Crystal Structure of a Conformation-selective Casein Kinase-1 Inhibitor* , 2000, The Journal of Biological Chemistry.

[19]  C. Malbon,et al.  Gαo mediates WNT-JNK signaling through Dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells , 2008, Journal of Cell Science.

[20]  William C. Skarnes,et al.  An LDL-receptor-related protein mediates Wnt signalling in mice , 2000, Nature.

[21]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[22]  P. Cohen,et al.  D4476, a cell‐permeant inhibitor of CK1, suppresses the site‐specific phosphorylation and nuclear exclusion of FOXO1a , 2004, EMBO reports.

[23]  Jeremy Nathans,et al.  A new member of the frizzled family from Drosophila functions as a Wingless receptor , 1996, Nature.

[24]  M. Almeida,et al.  Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by β-Catenin-dependent and -independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT* , 2005, Journal of Biological Chemistry.

[25]  Gustavo Pedraza-Alva,et al.  Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation , 2008, Science.

[26]  G. Cahill,et al.  Regulation of the Circadian Oscillator in Xenopus Retinal Photoreceptors by Protein Kinases Sensitive to the Stress-activated Protein Kinase Inhibitor, SB 203580* , 2004, Journal of Biological Chemistry.

[27]  L. Williams,et al.  Casein kinase iepsilon in the wnt pathway: regulation of beta-catenin function. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Brennan,et al.  Wnt Proteins Induce Dishevelled Phosphorylation via an LRP5/6- Independent Mechanism, Irrespective of Their Ability To Stabilize β-Catenin , 2004, Molecular and Cellular Biology.

[29]  G. Zaman,et al.  High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. , 2003, Assay and drug development technologies.

[30]  Joshua Wolf,et al.  Mitogen-Activated Protein Kinases Promote WNT/β-Catenin Signaling via Phosphorylation of LRP6 , 2010, Molecular and Cellular Biology.

[31]  W. Blankesteijn,et al.  β‐Galactosidase enzyme fragment complementation for the measurement of Wnt/β‐catenin signaling , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  L. Makings,et al.  A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. , 2002, Assay and drug development technologies.

[33]  K. Garber.  Drugging the Wnt pathway: problems and progress. , 2009, Journal of the National Cancer Institute.

[34]  Hans Clevers,et al.  The TAK1–NLK–MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF , 1999, Nature.

[35]  P. Nolan,et al.  When Clocks Go Bad: Neurobehavioural Consequences of Disrupted Circadian Timing , 2008, PLoS genetics.

[36]  G. Schulte,et al.  Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism , 2007, Journal of Cell Science.

[37]  B. Wittner,et al.  CK1\(\varepsilon\) is Required for Breast Cancers Dependent on \(\beta\)-Catenin Activity , 2010 .

[38]  Andrew Tomlinson,et al.  arrow encodes an LDL-receptor-related protein essential for Wingless signalling , 2000, Nature.

[39]  S. Jeon,et al.  Both ERK and Wnt/β-catenin pathways are involved in Wnt3a-induced proliferation , 2005, Journal of Cell Science.

[40]  Toshimasa Tanaka,et al.  Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent. , 2005, Journal of medicinal chemistry.

[41]  W. Blankesteijn,et al.  Stably overexpressed human Frizzled-2 signals through the beta-catenin pathway and does not activate Ca2+-mobilization in Human Embryonic Kidney 293 cells. , 2009, Cellular signalling.

[42]  Christof Niehrs,et al.  Casein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction , 2005, Nature.

[43]  S. Kassis,et al.  SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. , 2001, The Journal of pharmacology and experimental therapeutics.

[44]  A. Kozubík,et al.  Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration , 2010, Breast Cancer Research.

[45]  E. Krebs,et al.  Protein Serine/Threonine Kinases of the MAPK Cascade , 1995, Annals of the New York Academy of Sciences.

[46]  J. Graff,et al.  Casein kinase I transduces Wnt signals , 1999, Nature.

[47]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[48]  D. Alessi,et al.  Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis , 2005, The EMBO journal.

[49]  Ajamete Kaykas,et al.  Zebrafish Prickle, a Modulator of Noncanonical Wnt/Fz Signaling, Regulates Gastrulation Movements , 2003, Current Biology.